Hospira Gets 4 Of 5 Cubicin Patents Nixed
A Delaware federal judge on Monday invalidated four Cubist Pharmaceuticals Inc. patents for its blockbuster Cubicin, an intravenous antibiotic used to treat skin and blood infections, potentially clearing the way for...To view the full article, register now.
Already a subscriber? Click here to view full article